Laureate Acheives Record Growth in 2006

Laureate Pharma, Inc. has achieved record growth in 2006 with new agreements and business backlog up more than 240% from 2005. The company has increased its workforce 25% and is in the process of completing its facility expansion. Also, to help guide the company through its new services and emerging technologies evaluation, Laureate formed a scientific advisory board of industry leaders. According to the company, these factors support its strategic plan to position the company for continued growth for 2007 and beyond.

“We are extremely pleased with Laureate’s overall performance in 2006,” said Robert Broeze, president and chief executive officer at Laureate Pharma. “We have attracted an impressive list of clients and have made significant progress toward our goal of being the preferred CMO for the biopharmaceutical industry. We anticipate that our strong pipeline of projects, together with our commitment to our clients, will generate continued success going forward.”